Innovator Embraces Psychedelic Horizons With New Schedule 1 Manufacturing License

By Lara Goldstein

A new player is entering the psychedelics production space .

Small molecule therapeutic contract developer Societal CDMO Inc. (NASDAQ: SCTL ) has secured a DEA Schedule 1 Controlled Substances manufacturer's license and is entering the biopharma industry's psychedel

You are viewing a robot-friendly page.Click hereto reload in standard format.